Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.

van der Maas NA, Mollema L, Berbers GA, van Rooijen DM, van der Avoort HG, Conyn-Van Spaendonck MA, de Melker HE, van der Klis FR.

Euro Surveill. 2014 Feb 20;19(7):20705.

2.

[Introduction to vaccination against cervical cancer].

de Melker HE, Conyn-van Spaendonck MA, Boot HJ, Coutinho RA.

Ned Tijdschr Geneeskd. 2009 Apr 4;153(14):658-61. Dutch. No abstract available.

PMID:
19425324
3.

Mumps in a community with low vaccination coverage in the Netherlands.

Karagiannis I, van Lier A, van Binnendijk R, Ruijs H, Ruijs H, Fanoy E, Conyn-Van Spaendonck MA, de Melker H, Hahné S.

Euro Surveill. 2008 Jun 12;13(24). pii: 18901. No abstract available. Erratum in: Euro Surveill. 2008 Jun 19;13(25). pii: 18906.

4.

[The control of pertussis after half a century of vaccination].

Conyn-van Spaendonck MA.

Ned Tijdschr Geneeskd. 2008 Jan 12;152(2):66-8. Dutch.

PMID:
18265792
5.

Sudden deaths following influenza vaccination: can this be expected?

van der Sande MA, van Asten L, Straus SM, Schim van der Loeff MF, Wallinga J, Conyn-van Spaendonck MA.

Vaccine. 2008 Jan 17;26(3):379-82. Epub 2007 Nov 26.

PMID:
18082296
6.

[Adverse events following influenza vaccination: reaction to specific reports and the necessity of a central registration system].

Swaan CM, van der Sande MA, Speelman P, Conyn-van Spaendonck MA, Straus SM, Coutinho RA.

Ned Tijdschr Geneeskd. 2007 Sep 29;151(39):2166-9. Dutch.

PMID:
17957995
7.

Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.

Timen A, van Doornum GJ, Schutten M, Conyn-van Spaendonck MA, van der Meer JW, Osterhaus AD, van Steenbergen JE.

Clin Microbiol Infect. 2006 Dec;12(12):1214-20.

8.

Estimation of minimum infection rates with Legionella pneumophila in an exposed population.

Boshuizen HC, Nagelkerke NJ, Den Boer JW, De Melker H, Schellekens JF, Peeters MF, Van Vliet H, Conyn-Van Spaendonck MA.

Epidemiol Infect. 2006 Jun;134(3):579-84. Epub 2005 Oct 20.

9.

The seroepidemiology of Bordetella pertussis infection in Western Europe.

Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, Lévy-Bruhl D, Maple PA, de Melker H, Nardone A, Rota MC, Salmaso S, Conyn-van Spaendonck MA, Swidsinski S, Miller E.

Epidemiol Infect. 2005 Feb;133(1):159-71.

10.

Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.

Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MA.

J Infect Dis. 2005 Mar 15;191(6):990-9. Epub 2005 Feb 10.

PMID:
15717277
11.

Population-based Toxoplasma seroprevalence study in The Netherlands.

Kortbeek LM, De Melker HE, Veldhuijzen IK, Conyn-Van Spaendonck MA.

Epidemiol Infect. 2004 Oct;132(5):839-45.

12.

Reference values for the SERION classic ELISA for detecting Legionella pneumophila antibodies.

Boshuizen HC, Den Boer JW, de Melker H, Schellekens JF, Peeters MF, van Vliet JA, Conyn-van Spaendonck MA.

Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):706-8. Epub 2003 Oct 14. No abstract available.

PMID:
14557924
13.

Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands.

van Binnendijk RS, van den Hof S, van den Kerkhof H, Kohl RH, Woonink F, Berbers GA, Conyn-van Spaendonck MA, Kimman TG.

J Infect Dis. 2003 Sep 15;188(6):898-903. Epub 2003 Aug 25.

PMID:
12964122
14.

Descriptive epidemiology of exanthems in the Rotterdam region January 1997 to June 1998.

Ronveaux O, Bosman A, Reintjes R, Conyn-Van Spaendonck MA.

Euro Surveill. 1998 Dec;3(12):122-124.

PMID:
12631924
15.

The incidence of pertussis in the Netherlands has remained high since an outbreak occurred in 1996.

Neppelenbroek SE, De Melker HE, Schellekens JF, Conyn-Van Spaendonck MA.

Euro Surveill. 1999 Dec;4(12):133-134.

PMID:
12631880
16.

Options for improvement of the Dutch measles vaccination schedule.

van den Hof S, Wallinga J, Widdowson MA, Conyn-van Spaendonck MA.

Vaccine. 2003 Jan 30;21(7-8):721-4.

PMID:
12531348
17.
18.

Measles epidemic in the Netherlands, 1999-2000.

van den Hof S, Conyn-van Spaendonck MA, van Steenbergen JE.

J Infect Dis. 2002 Nov 15;186(10):1483-6. Epub 2002 Oct 29.

PMID:
12404165
19.

Immunoglobulin a as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population.

Herremans T, Kimman TG, Conyn-Van Spaendonck MA, Buisman A, de Melker H, Abbink F, Bijkerk P, Koopmans MP.

Clin Infect Dis. 2002 Apr 15;34(8):1067-75. Epub 2002 Mar 20.

PMID:
11914995
20.

Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules.

van den Hof S, Wallinga J, Widdowson MA, Conyn-van Spaendonck MA.

Epidemiol Infect. 2002 Feb;128(1):47-57.

21.

[Measles epidemic in the Netherlands, 1999-2000].

van den Hof S, van den Kerkhof JH, ten Ham PB, van Binnendijk RS, Conyn-van Spaendonck MA, van Steenbergen JE.

Ned Tijdschr Geneeskd. 2001 Dec 29;145(52):2529-33. Dutch.

PMID:
11793829
22.

A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999.

Den Boer JW, Yzerman EP, Schellekens J, Lettinga KD, Boshuizen HC, Van Steenbergen JE, Bosman A, Van den Hof S, Van Vliet HA, Peeters MF, Van Ketel RJ, Speelman P, Kool JL, Conyn-Van Spaendonck MA.

Emerg Infect Dis. 2002 Jan;8(1):37-43. Erratum in: Emerg Infect Dis 2002 Feb;8(2):180.

23.

Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands.

Oostvogel PM, Rumke HC, Conyn-Van Spaendonck MA, van der Avoort HG, Leeuwenburg J, van Loon AM.

J Infect Dis. 2001 Dec 1;184(11):1451-5. Epub 2001 Nov 13.

PMID:
11709788
24.

Measles outbreak in a community with very low vaccine coverage, the Netherlands.

van den Hof S, Meffre CM, Conyn-van Spaendonck MA, Woonink F, de Melker HE, van Binnendijk RS.

Emerg Infect Dis. 2001;7(3 Suppl):593-7.

25.

Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease.

Boshuizen HC, Neppelenbroek SE, van Vliet H, Schellekens JF, den Boer JW, Peeters MF, Conyn-van Spaendonck MA.

J Infect Dis. 2001 Aug 15;184(4):515-8. Epub 2001 Jul 16.

PMID:
11471112
26.

Immunity to poliomyelitis in The Netherlands.

Conyn-Van Spaendonck MA, de Melker HE, Abbink F, Elzinga-Gholizadea N, Kimman TG, van Loon T.

Am J Epidemiol. 2001 Feb 1;153(3):207-14.

PMID:
11157405
27.

The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.

Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, Hallander HO, Olander R, Maple PA, Melker HE, Olin P, Fievret-Groyne F, Rota C, Salmaso S, Tischer A, von-Hunolstein C, Miller E.

Epidemiol Infect. 2000 Aug;125(1):113-25. Erratum in: Epidemiol Infect 2001 Apr;126(2):331.

28.

The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey.

Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, van den Hof S, Conyn-Van Spaendonck MA.

Epidemiol Infect. 2000 Jun;124(3):459-66.

29.

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rümke HC, Conyn-van Spaendonck MA.

Emerg Infect Dis. 2000 Jul-Aug;6(4):348-57.

30.

[Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].

Conyn-van Spaendonck MA, Veldhuijzen IK, Suijkerbuijk AW, Hirasing RA.

Ned Tijdschr Geneeskd. 2000 May 27;144(22):1069-73. Dutch.

PMID:
10850110
31.

Non-participation in a population-based seroprevalence study of vaccine-preventable diseases.

De Melker HE, Nagelkerde NJ, Conyn-van Spaendonck MA.

Epidemiol Infect. 2000 Apr;124(2):255-62.

32.

Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, Schellekens JF.

J Clin Microbiol. 2000 Feb;38(2):800-6.

33.

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.

van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA.

Vaccine. 1999 Dec 10;18(9-10):931-40.

PMID:
10580207
34.

Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination.

de Haas R, van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA.

Epidemiol Infect. 1999 Oct;123(2):263-70.

35.

Diphtheria antitoxin levels in the Netherlands: a population-based study.

de Melker HE, Berbers GA, Nagelkerke NJ, Conyn-van Spaendonck MA.

Emerg Infect Dis. 1999 Sep-Oct;5(5):694-700.

36.

A population-based study on tetanus antitoxin levels in The Netherlands.

de Melker HE, van den Hof S, Berbers GA, Nagelkerke NJ, Rümke HC, Conyn-van Spaendonck MA.

Vaccine. 1999 Aug 20;18(1-2):100-8.

PMID:
10501240
37.

Meningococcal carriage in relation to an outbreak of invasive disease due to Neisseria meningitidis serogroup C in the Netherlands.

Conyn-van Spaendonck MA, Reintjes R, Spanjaard L, van Kregten E, Kraaijeveld AG, Jacobs PH.

J Infect. 1999 Jul;39(1):42-8.

PMID:
10468128
38.

Carriage of meningococci in contacts of patients with meningococcal disease. Age and other risk factors need to be taken into account.

Reintjes R, Conyn-van Spaendonck MA.

BMJ. 1999 Mar 6;318(7184):665-6. No abstract available.

PMID:
10215363
39.

A model-based evaluation of the national immunization programme against rubella infection and congenital rubella syndrome in The Netherlands.

van der Heijden OG, Conyn-van Spaendonck MA, Plantinga AD, Kretzschmar ME.

Epidemiol Infect. 1998 Dec;121(3):653-71.

40.

Immunosurveillance and the evaluation of national immunization programmes: a population-based approach.

De Melker HE, Conyn-van Spaendonck MA.

Epidemiol Infect. 1998 Dec;121(3):637-43.

41.

Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.

Herremans MM, Reimerink JH, Ras A, Van Der Avoort HG, Kimman TG, Van Loon AM, Conyn-Van Spaendonck MA, Koopmans MP.

Clin Diagn Lab Immunol. 1997 Nov;4(6):659-64.

42.

[Prevention of diphtheria].

Conyn-van Spaendonck MA.

Ned Tijdschr Geneeskd. 1997 May 24;141(21):1072-3. Dutch. No abstract available.

PMID:
9340568
43.

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.

de Melker HE, Conyn-van Spaendonck MA, Rümke HC, van Wijngaarden JK, Mooi FR, Schellekens JF.

Emerg Infect Dis. 1997 Apr-Jun;3(2):175-8.

44.

Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993.

Conyn-van Spaendonck MA, Oostvogel PM, van Loon AM, van Wijngaarden JK, Kromhout D.

Am J Epidemiol. 1996 May 1;143(9):929-35.

PMID:
8610706
46.

[Whooping cough in The Netherlands, 1989-1994].

de Melker HE, Conyn-van Spaendonck MA, Rümke HC, Sprenger MJ, Schellekens JF.

Ned Tijdschr Geneeskd. 1995 Jun 24;139(25):1280-6. Dutch.

PMID:
7609803
47.

[Pediatric surveillance of invasive infections caused by Haemophilus influenzae type b in children in the period following introduction of vaccination].

Conyn-van Spaendonck MA, Suijkerbuijk AW, Hirasing RA, van Pelt W.

Ned Tijdschr Geneeskd. 1995 Apr 29;139(17):885-90. Dutch.

PMID:
7739737
48.

[Measles in The Netherlands; epidemiology and the effect of vaccination].

van der Zwan CW, Plantinga AD, Rümke HC, Conyn-van Spaendonck MA.

Ned Tijdschr Geneeskd. 1994 Nov 26;138(48):2390-5. Dutch.

PMID:
7990986
49.

Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93.

Oostvogel PM, van Wijngaarden JK, van der Avoort HG, Mulders MN, Conyn-van Spaendonck MA, Rümke HC, van Steenis G, van Loon AM.

Lancet. 1994 Sep 3;344(8923):665-70.

PMID:
7915354
50.

[Evaluation of the hepatitis B prevention program in newborn infants. I. National data, 1990].

Grosheide PM, den Ouden AL, Verrips GH, Conyn-van Spaendonck MA, Loeber JG, Verloove-Vanhorick SP.

Ned Tijdschr Geneeskd. 1993 Dec 11;137(50):2589-94. Dutch.

PMID:
8277985

Supplemental Content

Loading ...
Support Center